Circulating Tumour DNA After Neoadjuvant Therapy in Non-Metastatic Colon Cancer: A Systematic Review and Implications for Surgical Decision-Making.

Cancers (Basel) · 2026 · PMC12984180 · PMID 41827748

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, patients who demonstrated an increase in ctDNA levels between baseline and surgery showed a trend toward lower 5-year disease-free survival (HR 3.66).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.